Socio-demographic
Sex 8 female, 7 male
Age (Years) 56.6 ± 2.4
BMI 34.0 ± 1.3
Anemia  
Hematocrit (%) 35.49 ± 0.61
HCT CALC (HGBX3) 34.94 ± 0.62
Hemoglobin (g/dL) 11.68 ± 0.20
Iron management
Iron saturation (%) 34.47 ± 3.51
Iron 79.57 ± 7.78
TIBC (µg/dL) 233.18 ± 9.05
UIBC (µg/dL) 149.67 ± 12.46
Osteodystrophy
Calcium (mg/dL) 9.11 ± 0.33
Phosphorus (mg/dL) 5.75 ± 0.48
Cal×Phos product 51.56 ± 4.48
Alkaline Phosphatase (mg/dL) 111.13 ± 20.40
Calcium corrected 9.35 ± 0.32
Cal×Phos product corrected 53.11 ± 4.68
Nutrition and Lipids  
Potassium (mg/dL) 4.49 ± 0.13
Albumin (mg/dL) 3.70 ± 0.10
Adequacy of dialysis and renal function  
Creatinine (µmoles/L) 7.44 ± 0.81
Blood Urea Nitrogen 54.73 ± 3.04
Kt/V (K=dialyzer clearance of urea, t=dialysis time and V=volume of distribution of urea in the body) 2.47 ± 0.13
Residual renal function (mL/Min) 6.68 ± 1.36
Duration of dialysis 9 patients (>6 months)
6 patients (<6 Months)
Dialysis regimen 2 patients were on CAPD
13 Patients were on CCPD
Table 1: Baseline characteristics of patients